↓ Skip to main content

Dove Medical Press

Article Metrics

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2021
Altmetric Badge

Mentioned by

twitter
1 tweeter

Readers on

mendeley
17 Mendeley
Title
Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology
Published in
Therapeutics and Clinical Risk Management, July 2021
DOI 10.2147/tcrm.s282390
Pubmed ID
Authors

Chiara Rosa Mancinelli, Nicola De Rossi, Ruggero Capra

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 12%
Student > Ph. D. Student 2 12%
Student > Bachelor 2 12%
Professor 1 6%
Student > Doctoral Student 1 6%
Other 5 29%
Unknown 4 24%
Readers by discipline Count As %
Medicine and Dentistry 6 35%
Neuroscience 3 18%
Computer Science 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Immunology and Microbiology 1 6%
Other 2 12%
Unknown 3 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2021.
All research outputs
#17,052,420
of 19,280,406 outputs
Outputs from Therapeutics and Clinical Risk Management
#1,056
of 1,161 outputs
Outputs of similar age
#266,228
of 334,853 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 3 outputs
Altmetric has tracked 19,280,406 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,161 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,853 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.